Investor Relations
Investors
View the Latest Stock Trading Information
Review BioStem’s latest trading data, historical quotes, volume, and key statistics.
News
Sign Up with Email Alerts Today.
Get news, filings, and events directly in your inbox with our automated Email Alerts
Symbol
OTC : BSEMPrice
$Volume
Change
Investor Relations
BioStem Technologies
Press Releases
Latest News
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental Allografts
BioStem Announces Notice of Allowance for U.S. Patent Application for Sterile Human Placental AllograftsCompany continues to advance its placental-derived product portfolio with the first patent granted in the fenestrated wound care market POMPANO BEACH, Fla., Nov....
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare GlobalAdditions of ProgenaMatrix® and revyve™ Antimicrobial Wound Gel part of planned expansion of BioStem’s commercial product portfolio...
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million
BioStem Technologies Reports Record Third Quarter 2024 Revenue of $82.6 Million Company reports third sequential quarter of record growth, contributing to a record total of $199.0 million in revenue for the first nine-months of 2024 Achieves third consecutive quarter...